
2025-03-07
Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy ʻO kahi ala lapaʻau maʻi maʻi hou e hui pū ana i ka hōʻoki ʻana me ka chemoimmunotherapy pilikino i hāʻawi pololei ʻia i loko o ka ʻōpū. Ke manaʻo nei kēia ʻano e hoʻonui i ka pono o ka lapaʻau ʻoiai e hōʻemi ana i nā hopena ʻaoʻao, hiki ke alakaʻi i nā hopena maʻi. Hoʻopili kēia ʻatikala i nā kikoʻī o kēia ʻenehana, me kona mau loina, nā kaʻina hana, nā pōmaikaʻi, a me nā kuhikuhi e hiki mai ana.
ʻO ka chemoimmunotherapy intratumoral ka hoʻokomo pololei ʻana i nā lāʻau chemotherapeutic a / a i ʻole immunotherapeutic agents i loko o kahi ʻōpū. Hāʻawi kēia hāʻawi kūloko i kahi kiʻekiʻe kiʻekiʻe o ka lāʻau lapaʻau e hōʻea i ka pūnaewele tumora, e hōʻemi ana i ka ʻike pūnaewele a me nā mea ʻawaʻawa i hoʻohālikelike ʻia i ka chemotherapy intravenous kuʻuna. Hoʻohana pinepine ʻia me nā lāʻau lapaʻau ʻē aʻe e like me ke ʻoki a i ʻole ka radiation therapy.
ʻO nā lāʻau lapaʻau maʻamau, e like me ka chemotherapy systemic a me ka radiation therapy, pili pinepine i ke kino holoʻokoʻa, e alakaʻi ana i nā hopena ʻaoʻao nui. Hōʻike ka Intratumoral therapy i ka neʻe ʻana i nā ala ʻoi aʻe i manaʻo ʻia a pilikino. Ma ka nānā pono ʻana i ka lāʻau lapaʻau ma luna o ka ʻōpū, manaʻo ia e mālama i nā ʻiʻo olakino a hoʻomaikaʻi i ka maikaʻi o ke ola o ka mea maʻi. Shandong Baofa Cancer Research Institute ua kūpaʻa i ka hana hou ma kēia kahua.
ʻO ka ʻaoʻao 'Ultra-Minimum Incision' e pili ana i ke ʻano hana ʻokiʻoki i hoʻohana ʻia no ke komo ʻana i ka maʻi maʻi no ka inikia. Hoʻopili maʻamau kēia i nā ʻoki liʻiliʻi, alakaʻi pinepine ʻia e nā ʻenehana kiʻi e like me ka ultrasound a i ʻole CT scans, e hōʻoia i ka hāʻawi pololei ʻana i nā mea lapaʻau. ʻO ke ʻano liʻiliʻi invasive o ke kaʻina hana e kōkua i ka wikiwiki o ka hoʻōla ʻana a me ka hōʻemi ʻana i ka ʻeha post-operative.
ʻO ka pilikino kahi mea nui o kēia ala. Ma mua o ka hoʻomaʻamaʻa ʻana, ʻike ʻia ka ʻōpū o ka mea maʻi e ʻike i kona mau ʻano kikoʻī, e like me nā genetic mutations a me nā hōʻailona immune. Hoʻohana ʻia kēia ʻike no ke koho ʻana i nā lāʻau chemotherapeutic a me immunotherapeutic kūpono loa no kēlā maʻi maʻi. ʻO kēia ala pilikino e hoʻonui i nā manawa o ka holomua lapaʻau a hoʻemi i ka hopena o nā hopena ʻino.
He mea koʻikoʻi ka loiloi biomarker no ka chemoimmunotherapy pilikino. Ma ka ʻike ʻana i nā biomarkers kikoʻī i loko o ka ʻōpū, hiki i nā kauka ke wānana i nā lāʻau lapaʻau e ʻoi aku ka maikaʻi. No ka laʻana, hiki i ka ʻōlelo PD-L1 ke hōʻike i ka pane ʻana i kekahi mau immunotherapies.
ʻO ka Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy ʻO ke kaʻina hana maʻamau e pili ana i kēia mau ʻanuʻu:
Hāʻawi kēia ʻano hana hou i kekahi mau pono kūpono e hoʻohālikelike ʻia i nā lāʻau lapaʻau kuʻuna maʻi maʻi:
ʻOiai ke hoʻomau nei ka noiʻi ʻana, Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy ua hōʻike i ka ʻōlelo hoʻohiki i ka mālama ʻana i nā maʻi maʻi like ʻole, e like me:
Nui nā hoʻokolohua lapaʻau e hoʻomaka ana e loiloi i ka palekana a me ka pono o Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy. Ke hoʻohiki nei nā hopena mua, me kekahi mau haʻawina e hōʻike ana i ka regression nui o ka maʻi tumora a me ka hoʻomaikaʻi ʻana i nā helu ola i nā maʻi i mālama ʻia me kēia ala. No ka laʻana, he haʻawina i paʻi ʻia ma ka Ka Nūpepa o Clinical Oncology ua hōʻike i ka holomua nui o ke ola holoʻokoʻa no nā poʻe maʻi me ka melanoma holomua i mālama ʻia me ka immunotherapy intratumoral i hoʻohālikelike ʻia me ka poʻe i mālama ʻia me ka chemotherapy systemic [1].
Ke ulu wikiwiki nei ke kahua o ka chemoimmunotherapy intratumoral. ʻO nā kuhikuhi i ka wā e hiki mai ana:
ʻAʻole nā kānaka maʻi a pau nā moho kūpono Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy. ʻO nā kumu e noʻonoʻo ai:
He mea nui ka loiloi piha ʻana e ka hui multidisciplinary o nā oncologists, nā kauā, a me nā mea lapaʻau ʻē aʻe e hoʻoholo ai inā kūpono kēia ala lapaʻau no kekahi mea maʻi. Hoʻokipa ʻia nā poʻe maʻi e ʻimi nei i ka ʻike hou aʻe e kelepona mai iā mākou no kahi kūkākūkā mua.
E like me kekahi hana lapaʻau, Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy lawe i kekahi mau pilikia a me nā hopena ʻaoʻao. Aia paha kēia mau mea:
He mea nui e kūkākūkā i kēia mau pilikia me kāu kauka ma mua o ka mālama ʻana.
ʻO ke kumukūʻai o Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy hiki ke ʻokoʻa ma muli o nā lāʻau lapaʻau i hoʻohana ʻia, ka paʻakikī o ke kaʻina hana, a me kahi o ke kikowaena lapaʻau. He mea nui e kūkākūkā i nā kumukūʻai me kāu ʻoihana mālama ola a me ka hui ʻinikua. He mea nui paha ka hiki ke komo, no ka mea, ʻaʻole i loaʻa nui kēia lāʻau lapaʻau ma nā kikowaena maʻi maʻi āpau.
Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy ʻO kahi ala hou e hoʻohiki ai i ka mālama ʻana i ka maʻi kanesa. Ma ka hoʻohui ʻana i ka hōʻoki liʻiliʻi invasive me ka chemoimmunotherapy pilikino, hāʻawi ia i ka hiki ke hoʻomaikaʻi i ka pono, hōʻemi i ka ʻona, a hoʻonui i ka maikaʻi o ke ola o ka mea maʻi. ʻOiai e koi ʻia ana ka noiʻi hou aʻe, paʻa kēia ala hou i ka hoʻohiki nui no ka wā e hiki mai ana o ka mālama maʻi kanesa. Ma Shandong Baofa Cancer Research Institute, ke hoʻomau nei mākou i ka hoʻolaʻa ʻana i ka holomua ʻana i ka mālama ʻana i ka maʻi kanesa a me ka hāʻawi ʻana i nā mea maʻi me ka mālama maikaʻi loa. E kelepona mai iā mākou e aʻo hou aʻe e pili ana i kā mākou mau koho lapaʻau lapaʻau piha.
[1] Ribas, A., et al. (2018). Intratumoral Immunotherapy. Ka Nūpepa o Clinical Oncology, 36(9), 919-927.